Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population, ...

SEATTLE — Third Avenue in Seattle is slowly getting a facelift. The newest addition is overhead lights that were strung ...

Winners of the 2024 Lasker Awards include researchers who discovered and developed GLP-1 agonists, infectious disease ...

The phase 1 portion is intended to determine the safety and the optimal dose of Covigenix VAX-002 as a COVID-19 booster vaccine ... and advance safe and effective RNA or DNA vaccines and therapeutics.

The conversation around Artificial Intelligence these days appears to be mostly negative. Very few people have anything ...

Australia has a hard-earned global reputation as a ‘go to’ destination to conduct clinical trials, which is continuing to ...

CSL and Arcturus Therapeutics have announced that Japan’s Ministry of Health, Labor and Welfare has granted approval for ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

About Aptevo Therapeutics Inc. Aptevo Therapeutics Inc. is a clinical ... including natural disasters or public health crises such as the coronavirus (referred to as COVID-19), geopolitical risks, ...